1
|
Inter-individual genomic heterogeneity within European population isolates. PLoS One 2019; 14:e0214564. [PMID: 31596857 PMCID: PMC6785074 DOI: 10.1371/journal.pone.0214564] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2019] [Accepted: 09/24/2019] [Indexed: 12/12/2022] Open
Abstract
A number of studies carried out since the early ‘70s has investigated the effects of isolation on genetic variation within and among human populations in diverse geographical contexts. However, no extensive analysis has been carried out on the heterogeneity among genomes within isolated populations. This issue is worth exploring since events of recent admixture and/or subdivision could potentially disrupt the genetic homogeneity which is to be expected when isolation is prolonged and constant over time. Here, we analyze literature data relative to 87,815 autosomal single-nucleotide polymorphisms, which were obtained from a total of 28 European populations. Our results challenge the traditional paradigm of population isolates as structured as genetically (and genomically) uniform entities. In fact, focusing on the distribution of variance of intra-population diversity measures across individuals, we show that the inter-individual heterogeneity of isolated populations is at least comparable to the open ones. More in particular, three small and highly inbred isolates (Sappada, Sauris and Timau in Northeastern Italy) were found to be characterized by levels of inter-individual heterogeneity largely exceeding that of all other populations, possibly due to relatively recent events of genetic introgression. Finally, we propose a way to monitor the effects of inter-individual heterogeneity in disease-gene association studies.
Collapse
|
2
|
Chheda H, Palta P, Pirinen M, McCarthy S, Walter K, Koskinen S, Salomaa V, Daly M, Durbin R, Palotie A, Aittokallio T, Ripatti S. Whole-genome view of the consequences of a population bottleneck using 2926 genome sequences from Finland and United Kingdom. Eur J Hum Genet 2017; 25:477-484. [PMID: 28145424 PMCID: PMC5346294 DOI: 10.1038/ejhg.2016.205] [Citation(s) in RCA: 52] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2016] [Revised: 12/05/2016] [Accepted: 12/14/2016] [Indexed: 12/14/2022] Open
Abstract
Isolated populations with enrichment of variants due to recent population bottlenecks provide a powerful resource for identifying disease-associated genetic variants and genes. As a model of an isolate population, we sequenced the genomes of 1463 Finnish individuals as part of the Sequencing Initiative Suomi (SISu) Project. We compared the genomic profiles of the 1463 Finns to a sample of 1463 British individuals that were sequenced in parallel as part of the UK10K Project. Whereas there were no major differences in the allele frequency of common variants, a significant depletion of variants in the rare frequency spectrum was observed in Finns when comparing the two populations. On the other hand, we observed >2.1 million variants that were twice as frequent among Finns compared with Britons and 800 000 variants that were more than 10 times more frequent in Finns. Furthermore, in Finns we observed a relative proportional enrichment of variants in the minor allele frequency range between 2 and 5% (P<2.2 × 10−16). When stratified by their functional annotations, loss-of-function variants showed the highest proportional enrichment in Finns (P=0.0291). In the non-coding part of the genome, variants in conserved regions (P=0.002) and promoters (P=0.01) were also significantly enriched in the Finnish samples. These functional categories represent the highest a priori power for downstream association studies of rare variants using population isolates.
Collapse
Affiliation(s)
- Himanshu Chheda
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
| | - Priit Palta
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.,Estonian Genome Center, University of Tartu, Tartu, Estonia
| | - Matti Pirinen
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
| | - Shane McCarthy
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK
| | - Klaudia Walter
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK
| | - Seppo Koskinen
- Department of Health, National Institute for Health and Welfare, Helsinki, Finland
| | - Veikko Salomaa
- Department of Health, National Institute for Health and Welfare, Helsinki, Finland
| | - Mark Daly
- Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.,Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.,Department of Genetics, Harvard Medical School, Boston, MA, USA
| | - Richard Durbin
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK
| | - Aarno Palotie
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.,Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.,Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.,Psychiatric & Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
| | - Tero Aittokallio
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.,Department of Mathematics and Statistics, University of Turku, Turku, Finland
| | - Samuli Ripatti
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.,Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.,Public Health, Clinicum, University of Helsinki, Helsinki, Finland
| |
Collapse
|
3
|
Overcoming the dichotomy between open and isolated populations using genomic data from a large European dataset. Sci Rep 2017; 7:41614. [PMID: 28145502 PMCID: PMC5286425 DOI: 10.1038/srep41614] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2016] [Accepted: 12/22/2016] [Indexed: 01/01/2023] Open
Abstract
Human populations are often dichotomized into “isolated” and “open” categories using cultural and/or geographical barriers to gene flow as differential criteria. Although widespread, the use of these alternative categories could obscure further heterogeneity due to inter-population differences in effective size, growth rate, and timing or amount of gene flow. We compared intra and inter-population variation measures combining novel and literature data relative to 87,818 autosomal SNPs in 14 open populations and 10 geographic and/or linguistic European isolates. Patterns of intra-population diversity were found to vary considerably more among isolates, probably due to differential levels of drift and inbreeding. The relatively large effective size estimated for some population isolates challenges the generalized view that they originate from small founding groups. Principal component scores based on measures of intra-population variation of isolated and open populations were found to be distributed along a continuum, with an area of intersection between the two groups. Patterns of inter-population diversity were even closer, as we were able to detect some differences between population groups only for a few multidimensional scaling dimensions. Therefore, different lines of evidence suggest that dichotomizing human populations into open and isolated groups fails to capture the actual relations among their genomic features.
Collapse
|
4
|
Haller T, Leitsalu L, Fischer K, Nuotio ML, Esko T, Boomsma DI, Kyvik KO, Spector TD, Perola M, Metspalu A. MixFit: Methodology for Computing Ancestry-Related Genetic Scores at the Individual Level and Its Application to the Estonian and Finnish Population Studies. PLoS One 2017; 12:e0170325. [PMID: 28107396 PMCID: PMC5249084 DOI: 10.1371/journal.pone.0170325] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2016] [Accepted: 01/03/2017] [Indexed: 01/05/2023] Open
Abstract
Ancestry information at the individual level can be a valuable resource for personalized medicine, medical, demographical and history research, as well as for tracing back personal history. We report a new method for quantitatively determining personal genetic ancestry based on genome-wide data. Numerical ancestry component scores are assigned to individuals based on comparisons with reference populations. These comparisons are conducted with an existing analytical pipeline making use of genotype phasing, similarity matrix computation and our addition-multidimensional best fitting by MixFit. The method is demonstrated by studying Estonian and Finnish populations in geographical context. We show the main differences in the genetic composition of these otherwise close European populations and how they have influenced each other. The components of our analytical pipeline are freely available computer programs and scripts one of which was developed in house (available at: www.geenivaramu.ee/en/tools/mixfit).
Collapse
Affiliation(s)
- Toomas Haller
- Estonian Genome Center, University of Tartu, Tartu, Estonia
| | - Liis Leitsalu
- Estonian Genome Center, University of Tartu, Tartu, Estonia
| | - Krista Fischer
- Estonian Genome Center, University of Tartu, Tartu, Estonia
| | - Marja-Liisa Nuotio
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
| | - Tõnu Esko
- Estonian Genome Center, University of Tartu, Tartu, Estonia
| | - Dorothea Irene Boomsma
- Vrije University, Department of Biological Psychology, Netherlands Twin Register, Amsterdam, The Netherlands
| | - Kirsten Ohm Kyvik
- Department of Clinical Research, University of Southern Denmark, Odense, Denmark
| | - Tim D. Spector
- The Department of Twin Research & Genetic Epidemiology, TwinsUK Registry, Kings College London, London, United Kingdom
| | - Markus Perola
- Estonian Genome Center, University of Tartu, Tartu, Estonia
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
- National Institute for Health and Welfare, Helskinki, Finland
| | | |
Collapse
|
5
|
Misiewicz Z, Hiekkalinna T, Paunio T, Varilo T, Terwilliger JD, Partonen T, Hovatta I. A genome-wide screen for acrophobia susceptibility loci in a Finnish isolate. Sci Rep 2016; 6:39345. [PMID: 27996024 PMCID: PMC5171840 DOI: 10.1038/srep39345] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2016] [Accepted: 11/16/2016] [Indexed: 12/02/2022] Open
Abstract
Acrophobia, an abnormal fear of heights, is a specific phobia characterized as apprehension cued by the occurrence or anticipation of elevated spaces. It is considered a complex trait with onset influenced by both genetic and environmental factors. Identification of genetic risk variants would provide novel insight into the genetic basis of the fear of heights phenotype and contribute to the molecular-level understanding of its aetiology. Genetic isolates may facilitate identification of susceptibility alleles due to reduced genetic heterogeneity. We took advantage of an internal genetic isolate in Finland in which a distinct acrophobia phenotype appears to be segregating in pedigrees originally ascertained for schizophrenia. We conducted parametric, nonparametric, joint linkage and linkage disequilibrium analyses using a microsatellite marker panel, genotyped in families to search for chromosomal regions correlated with acrophobia. Our results implicated a few regions with suggestive evidence for linkage on chromosomes 4q28 (LOD = 2.17), 8q24 (LOD = 2.09) and 13q21-q22 (LOD = 2.22). We observed no risk haplotypes shared between different families. These results suggest that genetic predisposition to acrophobia in this genetic isolate is unlikely to be mediated by a small number of shared high-risk alleles, but rather has a complex genetic architecture.
Collapse
Affiliation(s)
- Zuzanna Misiewicz
- Department of Biosciences, University of Helsinki, Helsinki, Finland
| | - Tero Hiekkalinna
- Department of Health, National Institute for Health and Welfare, Helsinki, Finland.,Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
| | - Tiina Paunio
- Department of Health, National Institute for Health and Welfare, Helsinki, Finland.,Department of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.,Development of Work and Work Organizations, Finnish Institute of Occupational Health, Helsinki, Finland
| | - Teppo Varilo
- Department of Medical Genetics, University of Helsinki, Helsinki, Finland
| | - Joseph D Terwilliger
- Department of Health, National Institute for Health and Welfare, Helsinki, Finland.,Department of Psychiatry, Department of Genetics and Development, and Gertrude H. Sergievsky Center, Columbia University, New York NY, USA.,Division of Medical Genetics, New York State Psychiatric Institute, New York NY, USA
| | - Timo Partonen
- Department of Health, National Institute for Health and Welfare, Helsinki, Finland
| | - Iiris Hovatta
- Department of Biosciences, University of Helsinki, Helsinki, Finland.,Department of Health, National Institute for Health and Welfare, Helsinki, Finland
| |
Collapse
|
6
|
Gontijo CC, Guerra Amorim CE, Godinho NMO, Toledo RCP, Nunes A, Silva W, Da Fonseca Moura MM, De Oliveira JCC, Pagotto RC, De Nazaré Klautau-Guimarães M, De Oliveira SF. Brazilian quilombos: A repository of Amerindian alleles. Am J Hum Biol 2014; 26:142-50. [DOI: 10.1002/ajhb.22501] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2013] [Revised: 12/05/2013] [Accepted: 12/15/2013] [Indexed: 11/05/2022] Open
Affiliation(s)
- Carolina Carvalho Gontijo
- Laboratório de Genética, Departamento de Genética e Morfologia; Instituto de Ciências Biológicas, Universidade de Brasília; 70910-900 Brasília DF Brazil
| | - Carlos Eduardo Guerra Amorim
- Laboratório de Genética, Departamento de Genética e Morfologia; Instituto de Ciências Biológicas, Universidade de Brasília; 70910-900 Brasília DF Brazil
| | - Neide Maria Oliveira Godinho
- Laboratório de Genética, Departamento de Genética e Morfologia; Instituto de Ciências Biológicas, Universidade de Brasília; 70910-900 Brasília DF Brazil
- Instituto de Criminalística Leonardo Rodrigues; 74425-030 Goiânia GO Brazil
| | - Rafaela Cesare Parmezan Toledo
- Laboratório de Genética, Departamento de Genética e Morfologia; Instituto de Ciências Biológicas, Universidade de Brasília; 70910-900 Brasília DF Brazil
| | - Adriana Nunes
- Departamento de Arqueologia; Universidade Federal de Rondônia; 76801-059 Porto Velho RO Brazil
| | - Wellington Silva
- Faculdade Adventista da Bahia; Caixa Postal 18 44300-000 Cachoeira BA Brazil
| | | | | | - Rubiani C. Pagotto
- Departamento de Biologia; Universidade Federal de Rondônia; 76801-059 Porto Velho RO Brazil
| | - Maria De Nazaré Klautau-Guimarães
- Laboratório de Genética, Departamento de Genética e Morfologia; Instituto de Ciências Biológicas, Universidade de Brasília; 70910-900 Brasília DF Brazil
| | - Silviene Fabiana De Oliveira
- Laboratório de Genética, Departamento de Genética e Morfologia; Instituto de Ciências Biológicas, Universidade de Brasília; 70910-900 Brasília DF Brazil
- Jackson Laboratory for Genomic Medicine; University of Connecticut Health Center; 06032 Farmington CT, USA
| |
Collapse
|
7
|
Pistis G, Okonkwo SU, Traglia M, Sala C, Shin SY, Masciullo C, Buetti I, Massacane R, Mangino M, Thein SL, Spector TD, Ganesh S, Pirastu N, Gasparini P, Soranzo N, Camaschella C, Hart D, Green MR, Toniolo D. Genome wide association analysis of a founder population identified TAF3 as a gene for MCHC in humans. PLoS One 2013; 8:e69206. [PMID: 23935956 PMCID: PMC3729833 DOI: 10.1371/journal.pone.0069206] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2013] [Accepted: 06/06/2013] [Indexed: 11/18/2022] Open
Abstract
The red blood cell related traits are highly heritable but their genetics are poorly defined. Only 5-10% of the total observed variance is explained by the genetic loci found to date, suggesting that additional loci should be searched using approaches alternative to large meta analysis. GWAS (Genome Wide Association Study) for red blood cell traits in a founder population cohort from Northern Italy identified a new locus for mean corpuscular hemoglobin concentration (MCHC) in the TAF3 gene. The association was replicated in two cohorts (rs1887582, P = 4.25E-09). TAF3 encodes a transcription cofactor that participates in core promoter recognition complex, and is involved in zebrafish and mouse erythropoiesis. We show here that TAF3 is required for transcription of the SPTA1 gene, encoding alpha spectrin, one of the proteins that link the plasma membrane to the actin cytoskeleton. Mutations in SPTA1 are responsible for hereditary spherocytosis, a monogenic disorder of MCHC, as well as for the normal MCHC level. Based on our results, we propose that TAF3 is required for normal erythropoiesis in human and that it might have a role in controlling the ratio between hemoglobin (Hb) and cell volume and in the dynamics of RBC maturation in healthy individuals. Finally, TAF3 represents a potential candidate or a modifier gene for disorders of red cell membrane.
Collapse
Affiliation(s)
- Giorgio Pistis
- Division of Genetics and Cell Biology, San Raffaele Research Institute and Vita Salute University, Milano, Italy
| | - Shawntel U. Okonkwo
- Cardiovascular Research Institute, University of California San Francisco, San Francisco, California, United States of America
| | - Michela Traglia
- Division of Genetics and Cell Biology, San Raffaele Research Institute and Vita Salute University, Milano, Italy
| | - Cinzia Sala
- Division of Genetics and Cell Biology, San Raffaele Research Institute and Vita Salute University, Milano, Italy
| | - So-Youn Shin
- Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom
| | - Corrado Masciullo
- Division of Genetics and Cell Biology, San Raffaele Research Institute and Vita Salute University, Milano, Italy
| | - Iwan Buetti
- Division of Genetics and Cell Biology, San Raffaele Research Institute and Vita Salute University, Milano, Italy
| | | | - Massimo Mangino
- Department of Twin Research & Genetic Epidemiology, King's College London, London, United Kingdom
| | - Swee-Lay Thein
- Department of Molecular Hematology, King’s College London, London, United Kingdom
| | - Timothy D. Spector
- Department of Twin Research & Genetic Epidemiology, King's College London, London, United Kingdom
| | - Santhi Ganesh
- Division of Cardiovascular Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of America
| | - Nicola Pirastu
- Medical Genetics, Department of Reproductive Sciences and Development, University of Trieste, Trieste, Italy
| | - Paolo Gasparini
- Medical Genetics, Department of Reproductive Sciences and Development, University of Trieste, Trieste, Italy
- Medical Genetics, Department of Laboratory Medicine, Institute for Maternal and Child Health IRCCS-Burlo Garofolo, Trieste, Italy
| | - Nicole Soranzo
- Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom
- Department of Twin Research & Genetic Epidemiology, King's College London, London, United Kingdom
| | - Clara Camaschella
- Division of Genetics and Cell Biology, San Raffaele Research Institute and Vita Salute University, Milano, Italy
| | - Daniel Hart
- Cardiovascular Research Institute, University of California San Francisco, San Francisco, California, United States of America
- Howard Hughes Medical Institute, Program in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
| | - Michael R. Green
- Howard Hughes Medical Institute, Program in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
| | - Daniela Toniolo
- Division of Genetics and Cell Biology, San Raffaele Research Institute and Vita Salute University, Milano, Italy
- Institute of Molecular Genetics-CNR, Pavia, Italy
| |
Collapse
|
8
|
Khrunin AV, Khokhrin DV, Filippova IN, Esko T, Nelis M, Bebyakova NA, Bolotova NL, Klovins J, Nikitina-Zake L, Rehnström K, Ripatti S, Schreiber S, Franke A, Macek M, Krulišová V, Lubinski J, Metspalu A, Limborska SA. A genome-wide analysis of populations from European Russia reveals a new pole of genetic diversity in northern Europe. PLoS One 2013; 8:e58552. [PMID: 23505534 PMCID: PMC3591355 DOI: 10.1371/journal.pone.0058552] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2012] [Accepted: 02/06/2013] [Indexed: 11/18/2022] Open
Abstract
Several studies examined the fine-scale structure of human genetic variation in Europe. However, the European sets analyzed represent mainly northern, western, central, and southern Europe. Here, we report an analysis of approximately 166,000 single nucleotide polymorphisms in populations from eastern (northeastern) Europe: four Russian populations from European Russia, and three populations from the northernmost Finno-Ugric ethnicities (Veps and two contrast groups of Komi people). These were compared with several reference European samples, including Finns, Estonians, Latvians, Poles, Czechs, Germans, and Italians. The results obtained demonstrated genetic heterogeneity of populations living in the region studied. Russians from the central part of European Russia (Tver, Murom, and Kursk) exhibited similarities with populations from central-eastern Europe, and were distant from Russian sample from the northern Russia (Mezen district, Archangelsk region). Komi samples, especially Izhemski Komi, were significantly different from all other populations studied. These can be considered as a second pole of genetic diversity in northern Europe (in addition to the pole, occupied by Finns), as they had a distinct ancestry component. Russians from Mezen and the Finnic-speaking Veps were positioned between the two poles, but differed from each other in the proportions of Komi and Finnic ancestries. In general, our data provides a more complete genetic map of Europe accounting for the diversity in its most eastern (northeastern) populations.
Collapse
Affiliation(s)
- Andrey V Khrunin
- Department of Molecular Bases of Human Genetics, Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Amorim CEG, Wang S, Marrero AR, Salzano FM, Ruiz-Linares A, Bortolini MC. X-chromosomal genetic diversity and linkage disequilibrium patterns in Amerindians and non-Amerindian populations. Am J Hum Biol 2011; 23:299-304. [PMID: 21294208 DOI: 10.1002/ajhb.21110] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2010] [Revised: 09/08/2010] [Accepted: 09/14/2010] [Indexed: 11/12/2022] Open
Affiliation(s)
- Carlos Eduardo G Amorim
- Programa de Pós-Graduação em Genética e Biologia Molecular and Departamento de Genética, Instituto de Biociências, Universidade Federal do Rio Grande do Sul, Caixa Postal 15053, 91501-970, Porto Alegre, RS, Brazil
| | | | | | | | | | | |
Collapse
|
10
|
Surakka I, Kristiansson K, Anttila V, Inouye M, Barnes C, Moutsianas L, Salomaa V, Daly M, Palotie A, Peltonen L, Ripatti S. Founder population-specific HapMap panel increases power in GWA studies through improved imputation accuracy and CNV tagging. Genome Res 2010; 20:1344-51. [PMID: 20810666 DOI: 10.1101/gr.106534.110] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
The combining of genome-wide association (GWA) data across populations represents a major challenge for massive global meta-analyses. Genotype imputation using densely genotyped reference samples facilitates the combination of data across different genotyping platforms. HapMap data is typically used as a reference for single nucleotide polymorphism (SNP) imputation and tagging copy number polymorphisms (CNPs). However, the advantage of having population-specific reference panels for founder populations has not been evaluated. We looked at the properties and impact of adding 81 individuals from a founder population to HapMap3 reference data on imputation quality, CNP tagging, and power to detect association in simulations and in an independent cohort of 2138 individuals. The gain in SNP imputation accuracy was highest among low-frequency markers (minor allele frequency [MAF] < 5%), for which adding the population-specific samples to the reference set increased the median R(2) between imputed and genotyped SNPs from 0.90 to 0.94. Accuracy also increased in regions with high recombination rates. Similarly, a reference set with population-specific extension facilitated the identification of better tag-SNPs for a subset of CNPs; for 4% of CNPs the R(2) between SNP genotypes and CNP intensity in the independent population cohort was at least twice as high as without the extension. We conclude that even a relatively small population-specific reference set yields considerable benefits in SNP imputation, CNP tagging accuracy, and the power to detect associations in founder populations and population isolates in particular.
Collapse
Affiliation(s)
- Ida Surakka
- Institute for Molecular Medicine Finland, FIMM, University of Helsinki, FI-00014 Helsinki, Finland
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Abstract
A cost-efficient way to increase power in a genetic association study is to pool controls from different sources. The genotyping effort can then be directed to large case series. The Nordic Control database, NordicDB, has been set up as a unique resource in the Nordic area and the data are available for authorized users through the web portal (http://www.nordicdb.org). The current version of NordicDB pools together high-density genome-wide SNP information from ∼5000 controls originating from Finnish, Swedish and Danish studies and shows country-specific allele frequencies for SNP markers. The genetic homogeneity of the samples was investigated using multidimensional scaling (MDS) analysis and pairwise allele frequency differences between the studies. The plot of the first two MDS components showed excellent resemblance to the geographical placement of the samples, with a clear NW-SE gradient. We advise researchers to assess the impact of population structure when incorporating NordicDB controls in association studies. This harmonized Nordic database presents a unique genome-wide resource for future genetic association studies in the Nordic countries.
Collapse
|
12
|
Wessman J, Paunio T, Tuulio-Henriksson A, Koivisto M, Partonen T, Suvisaari J, Turunen JA, Wedenoja J, Hennah W, Pietiläinen OPH, Lönnqvist J, Mannila H, Peltonen L. Mixture model clustering of phenotype features reveals evidence for association of DTNBP1 to a specific subtype of schizophrenia. Biol Psychiatry 2009; 66:990-6. [PMID: 19782967 DOI: 10.1016/j.biopsych.2009.05.034] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/01/2008] [Revised: 05/08/2009] [Accepted: 05/09/2009] [Indexed: 12/11/2022]
Abstract
BACKGROUND While DTNBP1, DISC1, and NRG1 have been extensively studied as candidate genes of schizophrenia, results remain inconclusive. Possible explanations for this are that the genes might be relevant only to certain subtypes of the disease and/or only in certain populations. METHODS We performed unsupervised clustering of individuals from Finnish schizophrenia families, based on extensive clinical and neuropsychological data, including Structured Clinical Interview for DSM-IV (SCID) information. Families with at least one affected member with DSM-IV diagnosis of a schizophrenia spectrum psychosis were included in a register-based ascertainment. Final sample consisted of 904 individuals from 288 families. We then used the cluster phenotypes in a genetic association study of candidate genes. RESULTS A robust three-class clustering of individuals emerged: 1) psychotic disorder with mood symptoms (n = 172), 2) core schizophrenia (n = 223), and 3) absence of psychotic disorder (n = 509). One third of the individuals diagnosed with schizophrenia were assigned to cluster 1. These individuals had fewer negative and positive psychotic symptoms and cognitive deficits but more depressive symptoms than individuals in cluster 2. There was a significant association of cluster 2 cases with the DTNBP1 gene, while the DISC1 gene indicated a significant association with schizophrenia spectrum disorders based on the DSM-IV criteria. CONCLUSIONS In the Finnish population, DTNBP1 gene is associated with a schizophrenia phenotype characterized by prominent negative symptoms, generalized cognitive impairment, and few mood symptoms. Identification of genes and pathways related to schizophrenia necessitates novel definitions of disease phenotypes associated more directly with underlying biology.
Collapse
Affiliation(s)
- Jaana Wessman
- Department of Molecular Medicine, Helsinki, Finland.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Leite FPN, Santos SEB, Rodríguez EMR, Callegari-Jacques SM, Demarchi DA, Tsuneto LT, Petzl-Erler ML, Salzano FM, Hutz MH. Linkage disequilibrium patterns and genetic structure of Amerindian and non-Amerindian Brazilian populations revealed by long-range X-STR markers. AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY 2009; 139:404-12. [PMID: 19170209 DOI: 10.1002/ajpa.20998] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The extent of X-chromosome linkage disequilibrium (LD) was studied in a southern Brazilian population, and in a pool of samples from Amerindian populations. For this purpose, 11 microsatellites, located mostly in a Xq region comprising approximately 86 Mb was investigated. The lower Amerindian gene diversity associated with significant differences between the populations studied indicated population structure as the main cause for the higher LD values in the Amerindian pool. On the other hand, the LD levels of the non-Amerindian Brazilian sample, although less extensive than that of the Amerindians, were probably determined by admixture events. Our results indicated that different demographic histories have significant effects on LD levels of human populations, and provide a first approach to the X-chromosome ancestry of Amerindian and non-Amerindian Brazilian populations, being valuable for future studies involving mapping and population genetic studies.
Collapse
Affiliation(s)
- Fabio P N Leite
- Laboratório de Perícias, Instituto Geral de Perícias, Porto Alegre, RS, Brazil
| | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Strait JB, Uda M, Lakatta EG, Najjar SS. Using new tools to define the genetic underpinnings of risky traits associated with coronary artery disease: the SardiNIA study. Trends Cardiovasc Med 2009; 19:69-75. [PMID: 19679263 DOI: 10.1016/j.tcm.2009.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Genomewide association studies are increasingly being applied to search for novel genes that might underlie cardiovascular diseases. In this article, we briefly review the principles that underlie modern genetic analyses and provide several illustrations from the SardiNIA study of genomewide association studies for cardiovascular risk factor traits.
Collapse
Affiliation(s)
- James B Strait
- Laboratory of Cardiovascular Science, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
| | | | | | | |
Collapse
|
15
|
Nelis M, Esko T, Mägi R, Zimprich F, Zimprich A, Toncheva D, Karachanak S, Piskáčková T, Balaščák I, Peltonen L, Jakkula E, Rehnström K, Lathrop M, Heath S, Galan P, Schreiber S, Meitinger T, Pfeufer A, Wichmann HE, Melegh B, Polgár N, Toniolo D, Gasparini P, D'Adamo P, Klovins J, Nikitina-Zake L, Kučinskas V, Kasnauskienė J, Lubinski J, Debniak T, Limborska S, Khrunin A, Estivill X, Rabionet R, Marsal S, Julià A, Antonarakis SE, Deutsch S, Borel C, Attar H, Gagnebin M, Macek M, Krawczak M, Remm M, Metspalu A. Genetic structure of Europeans: a view from the North-East. PLoS One 2009; 4:e5472. [PMID: 19424496 PMCID: PMC2675054 DOI: 10.1371/journal.pone.0005472] [Citation(s) in RCA: 237] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2009] [Accepted: 03/26/2009] [Indexed: 12/30/2022] Open
Abstract
Using principal component (PC) analysis, we studied the genetic constitution of 3,112 individuals from Europe as portrayed by more than 270,000 single nucleotide polymorphisms (SNPs) genotyped with the Illumina Infinium platform. In cohorts where the sample size was >100, one hundred randomly chosen samples were used for analysis to minimize the sample size effect, resulting in a total of 1,564 samples. This analysis revealed that the genetic structure of the European population correlates closely with geography. The first two PCs highlight the genetic diversity corresponding to the northwest to southeast gradient and position the populations according to their approximate geographic origin. The resulting genetic map forms a triangular structure with a) Finland, b) the Baltic region, Poland and Western Russia, and c) Italy as its vertexes, and with d) Central- and Western Europe in its centre. Inter- and intra- population genetic differences were quantified by the inflation factor lambda (λ) (ranging from 1.00 to 4.21), fixation index (Fst) (ranging from 0.000 to 0.023), and by the number of markers exhibiting significant allele frequency differences in pair-wise population comparisons. The estimated lambda was used to assess the real diminishing impact to association statistics when two distinct populations are merged directly in an analysis. When the PC analysis was confined to the 1,019 Estonian individuals (0.1% of the Estonian population), a fine structure emerged that correlated with the geography of individual counties. With at least two cohorts available from several countries, genetic substructures were investigated in Czech, Finnish, German, Estonian and Italian populations. Together with previously published data, our results allow the creation of a comprehensive European genetic map that will greatly facilitate inter-population genetic studies including genome wide association studies (GWAS).
Collapse
Affiliation(s)
- Mari Nelis
- Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia
- Estonian Biocentre, Genotyping Core Facility, Tartu, Estonia
| | - Tõnu Esko
- Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia
- Estonian Biocentre, Genotyping Core Facility, Tartu, Estonia
- Estonian Genome Project, University of Tartu, Tartu, Estonia
| | - Reedik Mägi
- Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia
- OÜ BioData, Tartu, Estonia
| | - Fritz Zimprich
- Department of Clinical Neurology, Medical University of Vienna, Vienna, Austria
| | - Alexander Zimprich
- Department of Clinical Neurology, Medical University of Vienna, Vienna, Austria
| | - Draga Toncheva
- Department of Medical Genetics, Medical University of Sofia, Sofia, Bulgaria
| | - Sena Karachanak
- Department of Medical Genetics, Medical University of Sofia, Sofia, Bulgaria
| | - Tereza Piskáčková
- Department of Biology and Medical Genetics, Cystic Fibrosis Centre, University Hospital Motol and 2nd School of Medicine, Charles University Prague, Prague, Czech Republic
| | - Ivan Balaščák
- Department of Neonatology, Clinic of Obstetrics and Gynecology, University Hospital Motol and 2nd School of Medicine, Charles University Prague, Prague, Czech Republic
| | - Leena Peltonen
- Wellcome Trust Sanger Institute, Cambridge, UK and the Institute of Molecular Medicine, Biomedicum Helsinki, Helsinki, Finland
| | - Eveliina Jakkula
- Institute for Molecular Medicine Finland (FIMM) and National Institute for Health and Welfare, Helsinki, Finland
| | - Karola Rehnström
- Institute for Molecular Medicine Finland (FIMM) and National Institute for Health and Welfare, Helsinki, Finland
| | - Mark Lathrop
- Commissariat à l'Energie Atomique, Institut Genomique, Centre National de Génotypage, Evry, France
- Fondation Jean Dausset-CEPH, Paris, France
| | - Simon Heath
- Commissariat à l'Energie Atomique, Institut Genomique, Centre National de Génotypage, Evry, France
| | - Pilar Galan
- UMR U557 Inserm, U1125 Inra, Cnam, Paris 13, Paris, France
| | - Stefan Schreiber
- PopGen Biobank, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - Thomas Meitinger
- Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- Institute of Human Genetics, Technische Universität München, Klinikum rechts der Isar, Munich, Germany
| | - Arne Pfeufer
- Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- Institute of Human Genetics, Technische Universität München, Klinikum rechts der Isar, Munich, Germany
| | - H-Erich Wichmann
- Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- Institute of Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany
| | - Béla Melegh
- Department of Medical Genetics and Child Development, University of Pécs, Pécs, Hungary
| | - Noémi Polgár
- Department of Medical Genetics and Child Development, University of Pécs, Pécs, Hungary
| | - Daniela Toniolo
- Division of Genetics and Cell Biology, San Raffaele Research Institute, Milano, Italy
| | - Paolo Gasparini
- Medical Genetics, Department of Reproductive Sciences and Development, IRCCS-Burlo Garofolo, University of Trieste, Trieste, Italy
| | - Pio D'Adamo
- Medical Genetics, Department of Reproductive Sciences and Development, IRCCS-Burlo Garofolo, University of Trieste, Trieste, Italy
| | - Janis Klovins
- Latvian Biomedical Research and Study Center, Riga, Latvia
| | | | - Vaidutis Kučinskas
- Department of Human and Medical Genetics, Vilnius University, Vilnius, Lithuania
| | - Jūratė Kasnauskienė
- Department of Human and Medical Genetics, Vilnius University, Vilnius, Lithuania
| | - Jan Lubinski
- International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
| | - Tadeusz Debniak
- International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
| | - Svetlana Limborska
- Institute of Molecular Genetics, Russian Academy of Science, Moscow, Russia
| | - Andrey Khrunin
- Institute of Molecular Genetics, Russian Academy of Science, Moscow, Russia
| | - Xavier Estivill
- Center for Genomic Regulation (CRG-UPF) and CIBERESP, Barcelona, Spain
| | - Raquel Rabionet
- Center for Genomic Regulation (CRG-UPF) and CIBERESP, Barcelona, Spain
| | - Sara Marsal
- Rheumatology Research group, Vall d'Hebron University Hospital Research Institute, Barcelona, Spain
| | - Antonio Julià
- Rheumatology Research group, Vall d'Hebron University Hospital Research Institute, Barcelona, Spain
| | - Stylianos E. Antonarakis
- Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland
| | - Samuel Deutsch
- Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland
| | - Christelle Borel
- Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland
| | - Homa Attar
- Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland
| | - Maryline Gagnebin
- Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland
| | - Milan Macek
- Department of Biology and Medical Genetics, Cystic Fibrosis Centre, University Hospital Motol and 2nd School of Medicine, Charles University Prague, Prague, Czech Republic
| | - Michael Krawczak
- PopGen Biobank, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - Maido Remm
- Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia
| | - Andres Metspalu
- Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia
- Estonian Biocentre, Genotyping Core Facility, Tartu, Estonia
- Estonian Genome Project, University of Tartu, Tartu, Estonia
- * E-mail:
| |
Collapse
|
16
|
Terwilliger JD, Hiekkalinna T. An utter refutation of the "fundamental theorem of the HapMap". Eur J Hum Genet 2009; 14:426-37. [PMID: 16479260 DOI: 10.1038/sj.ejhg.5201583] [Citation(s) in RCA: 107] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
The International HapMap Project was proposed in order to quantify linkage disequilibrium (LD) relationships among human DNA polymorphisms in an assortment of populations, in order to facilitate the process of selecting a minimal set of markers that could capture most of the signal from the untyped markers in a genome-wide association study. The central dogma can be summarized by the argument that if a marker is in tight LD with a polymorphism that directly impacts disease risk, as measured by the metric r(2), then one would be able to detect an association between the marker and disease with sample size that was increased by a factor of 1/r(2) over that needed to detect the effect of the functional variant directly. This "fundamental theorem" holds, however, only if one assumes that the LD between loci and the etiological effect of the functional variant are independent of each other, that they are statistically independent of all other etiological factors (in exposure and action), that sampling is prospective, and that the estimates of r(2) are accurate. None of these are standard operating assumptions, however. We describe the ramifications of these implicit assumptions, and provide simple examples in which the effects of a functional variant could be unequivocally detected if it were directly genotyped, even as markers in high LD with the functional variant would never show association with disease, even in infinite sample sizes. Both theoretical and empirical refutation of the central dogma of genome-wide association studies is thus presented.
Collapse
|
17
|
Abstract
The Finnish population in Northern Europe has been a target of extensive genetic studies during the last decades. The population is considered as a homogeneous isolate, well suited for gene mapping studies because of its reduced diversity and homogeneity. However, several studies have shown substantial differences between the eastern and western parts of the country, especially in the male-mediated Y chromosome. This divergence is evident in non-neutral genetic variation also and it is usually explained to stem from founder effects occurring in the settlement of eastern Finland as late as in the 16th century. Here, we have reassessed this population historical scenario using Y-chromosomal, mitochondrial and autosomal markers and geographical sampling covering entire Finland. The obtained results suggest substantial Scandinavian gene flow into south-western, but not into the eastern, Finland. Male-biased Scandinavian gene flow into the south-western parts of the country would plausibly explain the large inter-regional differences observed in the Y-chromosome, and the relative homogeneity in the mitochondrial and autosomal data. On the basis of these results, we suggest that the expression of 'Finnish Disease Heritage' illnesses, more common in the eastern/north-eastern Finland, stems from long-term drift, rather than from relatively recent founder effects.
Collapse
|
18
|
Zarrabeitia MT, Pinheiro F, de Pancorbo MM, Cainé L, Cardoso S, Gusmão L, Riancho JA. Analysis of 10 X-linked tetranucleotide markers in mixed and isolated populations. Forensic Sci Int Genet 2009; 3:63-6. [DOI: 10.1016/j.fsigen.2008.10.001] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2008] [Revised: 09/21/2008] [Accepted: 10/02/2008] [Indexed: 11/28/2022]
|
19
|
Bellis C, Cox HC, Dyer TD, Charlesworth JC, Begley KN, Quinlan S, Lea RA, Heath SC, Blangero J, Griffiths LR. Linkage mapping of CVD risk traits in the isolated Norfolk Island population. Hum Genet 2008; 124:543-52. [PMID: 18975005 DOI: 10.1007/s00439-008-0580-y] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2008] [Accepted: 10/21/2008] [Indexed: 01/04/2023]
Abstract
To understand the underlying genetic architecture of cardiovascular disease (CVD) risk traits, we undertook a genome-wide linkage scan to identify CVD quantitative trait loci (QTLs) in 377 individuals from the Norfolk Island population. The central aim of this research focused on the utilization of a genetically and geographically isolated population of individuals from Norfolk Island for the purposes of variance component linkage analysis to identify QTLs involved in CVD risk traits. Substantial evidence supports the involvement of traits such as systolic and diastolic blood pressures, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, body mass index and triglycerides as important risk factors for CVD pathogenesis. In addition to the environmental influences of poor diet, reduced physical activity, increasing age, cigarette smoking and alcohol consumption, many studies have illustrated a strong involvement of genetic components in the CVD phenotype through family and twin studies. We undertook a genome scan using 400 markers spaced approximately 10 cM in 600 individuals from Norfolk Island. Genotype data was analyzed using the variance components methods of SOLAR. Our results gave a peak LOD score of 2.01 localizing to chromosome 1p36 for systolic blood pressure and replicated previously implicated loci for other CVD relevant QTLs.
Collapse
Affiliation(s)
- C Bellis
- Genomics Research Centre, Griffith Institute for Health and Medical Research, Griffith University, Gold Coast PMB 50, GCMC Bundall 9726, Gold Coast, Australia.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Wedenoja J, Loukola A, Tuulio-Henriksson A, Paunio T, Ekelund J, Silander K, Varilo T, Heikkilä K, Suvisaari J, Partonen T, Lönnqvist J, Peltonen L. Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families. Mol Psychiatry 2008; 13:673-84. [PMID: 17684500 DOI: 10.1038/sj.mp.4002047] [Citation(s) in RCA: 76] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Schizophrenia is a common and complex mental disorder. Hereditary factors are important for its etiology, but despite linkage signals reported to several chromosomal regions in different populations, final identification of predisposing genes has remained a challenge. Utilizing a large family-based schizophrenia study sample from Finland, we have identified several linked loci: 1q32.2-q42, 2q, 4q31, 5q and 7q22. In this study, an independent sample of 352 nuclear schizophrenia families (n=1626) allowed replication of linkage on 7q21-32. In a sample of 245 nuclear families (n=1074) originating from the same geographical region as the families revealing the linkage, SNP and microsatellite association analyses of the four regional candidate genes, GRM3, RELN, SEMA3A and VGF, revealed no significant association to the clinical diagnosis of schizophrenia. Instead, quantifiable trait component analyses with neuropsychological endophenotypes available from 186 nuclear families (n=861) of the sample showed significant association to RELN variants for traits related to verbal (P=0.000003) and visual working memory (P=0.002), memory (P=0.002) and executive functioning (P=0.002). Trait-associated allele-positive subjects scored lower in the tests measuring working memory (P=0.0004-0.0000000004), memory (P=0.02-0.0001) and executive functioning (P=0.001). Our findings suggest that allelic variants of RELN contribute to the endophenotypes of schizophrenia.
Collapse
Affiliation(s)
- J Wedenoja
- Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Branco CC, Cabrol E, Bento MS, Gomes CT, Cabral R, Vicente AM, Pacheco PR, Mota-Vieira L. Evaluation of linkage disequilibrium on the Xq13.3 region: Comparison between the Azores islands and mainland Portugal. Am J Hum Biol 2008; 20:364-6. [DOI: 10.1002/ajhb.20734] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
22
|
Bellis C, Cox HC, Ovcaric M, Begley KN, Lea RA, Quinlan S, Burgner D, Heath SC, Blangero J, Griffiths LR. Linkage disequilibrium analysis in the genetically isolated Norfolk Island population. Heredity (Edinb) 2007; 100:366-73. [PMID: 18091769 DOI: 10.1038/sj.hdy.6801083] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
Norfolk Island is a human genetic isolate, possessing unique population characteristics that could be utilized for complex disease gene localization. Our intention was to evaluate the extent and strength of linkage disequilibrium (LD) in the Norfolk isolate by investigating markers within Xq13.3 and the NOS2A gene encoding the inducible nitric oxide synthase. A total of six microsatellite markers spanning approximately 11 Mb were assessed on chromosome Xq13.3 in a group of 56 men from Norfolk Island. Additionally, three single nucleotide polymorphisms (SNPs) localizing to the NOS2A gene were analyzed in a subset of the complex Norfolk pedigree. With the exception of two of the marker pairs, one of which is the most distantly spaced marker, all the Xq13.3 marker pairs were found to be in significant LD indicating that LD extends up to 9.5-11.5 Mb in the Norfolk Island population. Also, all SNPs studied showed significant LD in both Norfolk Islanders and Australian Caucasians, with two of the marker pairs in complete LD in the Norfolk population only. The Norfolk Island study population possesses a unique set of characteristics including founder effect, geographical isolation, exhaustive genealogical information and phenotypic data of use to cardiovascular disease risk traits. With LD extending up to 9.5-11 Mb, the Norfolk isolate should be a powerful resource for the localization of complex disease genes.
Collapse
Affiliation(s)
- C Bellis
- Genomics Research Centre, School of Medical Science, Griffith University, Gold Coast, Bundall, Australia
| | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Haukka J, Suvisaari J, Tuulio-Henriksson A, Lönnqvist J. High concordance between self-reported medication and official prescription database information. Eur J Clin Pharmacol 2007; 63:1069-74. [PMID: 17712552 DOI: 10.1007/s00228-007-0349-6] [Citation(s) in RCA: 83] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2007] [Accepted: 07/06/2007] [Indexed: 11/24/2022]
Abstract
OBJECTIVE We set out to compare the agreement between self-reported psychotropic medication use and information obtained from the administrative prescription database of the Social Insurance Institution of Finland. We compared the point prevalence of psychotropic medication use, and self-reported vs. register-based information on antipsychotic medication dosage. METHODS The study population consisted of 905 participants from a population-based genetic study of schizophrenia, of whom 366 had schizophrenia spectrum disorder, 56 had bipolar spectrum disorder, and 483 were unaffected family members. Current medication use was obtained by interview and from the prescription reimbursement database. Agreement between data sources was compared using Cohen's kappa statistic and correlation coefficients. RESULTS The agreement between the two sources was generally good. Kappa values were best for lithium use (0.96; p < 0.0001), followed by antipsychotics (0.87; p < 0.0001) and antidepressants (0.77; p < 0.0001). Agreement was lowest for benzodiazepines (0.42; p < 0.0001). Correlation between antipsychotic medication dose estimates was 0.79 (95% CI 0.76-0.81). CONCLUSION The concordance between self-reported psychotropic medication use and information obtained from an official prescription database was good for most psychotropic drugs. More studies are needed to replicate results with other forms of medication and patient groups.
Collapse
Affiliation(s)
- Jari Haukka
- Department for Mental Health and Alcohol Research, Mannerheimintie 166, 00300, Helsinki, Finland.
| | | | | | | |
Collapse
|
24
|
Demographic changes and marker properties affect detection of human population differentiation. BMC Genet 2007; 8:21. [PMID: 17498298 PMCID: PMC1876243 DOI: 10.1186/1471-2156-8-21] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2006] [Accepted: 05/11/2007] [Indexed: 01/02/2023] Open
Abstract
BACKGROUND Differentiating genetically between populations is valuable for admixture and population stratification detection and in understanding population history. This is easy to achieve for major continental populations, but not for closely related populations. It has been claimed that a large marker panel is necessary to reliably distinguish populations within a continent. We investigated whether empirical genetic differentiation could be accomplished efficiently among three Asian populations (Hmong, Thai, and Chinese) using a small set of highly variable markers (15 tetranucleotide and 17 dinucleotide repeats). RESULTS Hmong could be differentiated from Thai and Chinese based on multi-locus genotypes, but Thai and Chinese were indistinguishable from each other. We found significant evidence for a recent population bottleneck followed by expansion in the Hmong that was not present in the Thai or Chinese. Tetranucleotide repeats were less useful than dinucleotide repeat markers in distinguishing between major continental populations (Asian, European, and African) while both successfully distinguished Hmong from Thai and Chinese. CONCLUSION Demographic history contributes significantly to robust detection of intracontinental population structure. Populations having experienced a rapid size reduction may be reliably distinguished as a result of a genetic drift -driven redistribution of population allele frequencies. Tetranucleotide markers, which differ from dinucleotide markers in mutation mechanism and rate, are similar in information content to dinucleotide markers in this situation. These factors should be considered when identifying populations suitable for gene mapping studies and when interpreting interpopulation relationships based on microsatellite markers.
Collapse
|
25
|
Salmela E, Taskinen O, Seppänen JK, Sistonen P, Daly MJ, Lahermo P, Savontaus ML, Kere J. Subpopulation difference scanning: a strategy for exclusion mapping of susceptibility genes. J Med Genet 2006; 43:590-7. [PMID: 16443857 PMCID: PMC2564554 DOI: 10.1136/jmg.2005.038414] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND Association mapping is a common strategy for finding disease-related genes in complex disorders. Different association study designs exist, such as case-control studies or admixture mapping. METHODS We propose a strategy, subpopulation difference scanning (SDS), to exclude large fractions of the genome as locations of genes for complex disorders. This strategy is applicable to genes explaining disease incidence differences within founder populations, for example, in cardiovascular diseases in Finland. RESULTS The strategy consists of genotyping a set of markers from unrelated individuals sampled from subpopulations with differing disease incidence but otherwise as similar as possible. When comparing allele or haplotype frequencies between the subpopulations, the genomic areas with little difference can be excluded as possible locations for genes causing the difference in incidence, and other areas therefore targeted with case-control studies. As tests of this strategy, we use real and simulated data to show that under realistic assumptions of population history and disease risk parameters, the strategy saves efforts of sampling and genotyping and most efficiently detects genes of low risk--that is, those most difficult to find with other strategies. CONCLUSION In contrast to admixture mapping that uses the mixing of two different populations, the SDS strategy takes advantage of drift within highly related subpopulations.
Collapse
Affiliation(s)
- E Salmela
- Finnish Genome Center, University of Helsinki, Finland
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Laan M, Wiebe V, Khusnutdinova E, Remm M, Pääbo S. X-chromosome as a marker for population history: linkage disequilibrium and haplotype study in Eurasian populations. Eur J Hum Genet 2005; 13:452-62. [PMID: 15657606 PMCID: PMC1450114 DOI: 10.1038/sj.ejhg.5201340] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
Linkage disequilibrium (LD) structure is still unpredictable because the interplay of regional recombination rate and demographic history is poorly understood. We have compared the distribution of LD across two genomic regions differing in crossing-over activity -- Xq13 (0.166 cM/Mb) and Xp22 (1.3 cM/Mb) -- in 15 Eurasian populations. Demographic events predicted to increase the LD level -- genetic drift, bottleneck and admixture - had a very strong impact on extent and patterns of regional LD across Xq13 compared to Xp22. The haplotype distribution of the DXS1225-DXS8082 microsatellites from Xq13 exhibiting strong association in all populations was remarkably influenced by population history. European populations shared one common haplotype with a frequency of 25-40%. The Volga-Ural populations studied, living at the geographic borderline of Europe, showed elevated LD as well as harboring a significant fraction of haplotypes originating from East Asia, thus reflecting their past migrations and admixture. In the young Kuusamo isolate from Finland, a bottleneck has led to allelic associations between loci and shifted the haplotype distribution, but has much less affected single microsatellite allele frequencies compared to the main Finnish population. The data show that the footprint of a demographic event is longer preserved in haplotype distribution within a region of low crossing-over rate, than in the information content of a single marker, or between actively recombining markers. As the knowledge of LD patterns is often chosen to assist association mapping of common disease, our conclusions emphasize the importance of understanding the history, structure and variation of a study population.
Collapse
Affiliation(s)
- Maris Laan
- Department of Biotechnology, Institute of Molecular and Cell Biology, University of Tartu, Estonia.
| | | | | | | | | |
Collapse
|
27
|
Johansson A, Vavruch-Nilsson V, Edin-Liljegren A, Sjölander P, Gyllensten U. Linkage disequilibrium between microsatellite markers in the Swedish Sami relative to a worldwide selection of populations. Hum Genet 2004; 116:105-13. [PMID: 15549393 DOI: 10.1007/s00439-004-1213-8] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2004] [Accepted: 10/07/2004] [Indexed: 11/25/2022]
Abstract
The pattern of linkage disequilibrium (LD) is affected by a number of factors, including population demography. High LD is seen in populations with a relatively limited and constant size, presumably because of genetic drift. We have examined the extent of LD among over 300 genome-wide pattern microsatellite loci in 29 populations from around the world. The pattern of LD varied between populations, with a larger extent of LD in populations with limited size relative to larger populations. In addition, the LD between 88 less well-spaced microsatellite markers from 10 different genomic regions was examined in the Sami compared with the general Swedish population. For these markers, increased LD extending up to 5 Mb was detected in the Sami. The amount of LD also differed between the chromosomal regions. The amount of LD in the Sami makes this population suitable for the mapping of complex genetic traits.
Collapse
Affiliation(s)
- Asa Johansson
- Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 57185 Uppsala, Sweden
| | | | | | | | | |
Collapse
|
28
|
Latini V, Sole G, Doratiotto S, Poddie D, Memmi M, Varesi L, Vona G, Cao A, Ristaldi MS. Genetic isolates in Corsica (France): linkage disequilibrium extension analysis on the Xq13 region. Eur J Hum Genet 2004; 12:613-9. [PMID: 15114371 DOI: 10.1038/sj.ejhg.5201205] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Genetic isolates with a history of a small founder population, long-lasting isolation and population bottlenecks represent exceptional resources in the identification of genes involved in the pathogenesis of multifactorial diseases. In these populations, the disease allele reveals linkage disequilibrium (LD) with markers over significant genetic intervals, therefore facilitating disease locus identification. This study has been designed to examine the background LD extension in some subpopulations of Corsica. Our interest in the island of Corsica is due to its geographical and genetic proximity to the other Mediterranean island of Sardinia. Sardinian isolates in which the extension of the background LD is particularly high have been recently identified and are now the object of studies aimed at the mapping of genes involved in complex diseases. Recent evidence has highlighted that the genetic proximity between the populations of Corsica and Sardinia is particularly true for the internal conservative populations. Given these considerations, Sardinia and Corsica may represent a unique system to carry out parallel association studies whose results could be validated by comparison. In the present study, we have analyzed the LD extension on the Xq13 genomic region in three subpopulations of Corsica: Corte, Niolo and Bozio, all located in the mountainous north-center of the island. Our results show a strong degree of LD over long distance for the population of Bozio and to a less extent for the population of Niolo. Their LD extent is comparable to or higher than that reported for other isolates.
Collapse
Affiliation(s)
- Veronica Latini
- Istituto di Neurogenetica e Neurofarmacologia Consiglio Nazionale delle Ricerche (INN-CNR), Cagliari, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Aulchenko YS, Heutink P, Mackay I, Bertoli-Avella AM, Pullen J, Vaessen N, Rademaker TAM, Sandkuijl LA, Cardon L, Oostra B, van Duijn CM. Linkage disequilibrium in young genetically isolated Dutch population. Eur J Hum Genet 2004; 12:527-34. [PMID: 15054401 DOI: 10.1038/sj.ejhg.5201188] [Citation(s) in RCA: 86] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
The design and feasibility of genetic studies of complex diseases are critically dependent on the extent and distribution of linkage disequilibrium (LD) across the genome and between different populations. We have examined genomewide and region-specific LD in a young genetically isolated population identified in the Netherlands by genotyping approximately 800 Short Tandem Repeat markers distributed genomewide across 58 individuals. Several regions were analyzed further using a denser marker map. The permutation-corrected measure of LD was used for analysis. A significant (P<0.0004) relation between LD and genetic distance on a genomewide scale was found. Distance explained 4% of the total LD variation. For fine-mapping data, distance accounted for a larger proportion of LD variation (up to 39%). A notable similarity in the genomewide distribution of LD was revealed between this population and other young genetically isolated populations from Micronesia and Costa Rica. Our study population and experiment was simulated in silico to confirm our knowledge of the history of the population. High agreement was observed between results of analysis of simulated and empirical data. We conclude that our population shows a high level of LD similar to that demonstrated previously in other young genetic isolates. In Europe, there may be a large number of young genetically isolated populations that are similar in history to ours. In these populations, a similar degree of LD is expected and thus they may be effectively used for linkage or LD mapping.
Collapse
Affiliation(s)
- Yurii S Aulchenko
- Department of Epidemiology and Biostatistics, Erasmus Medical Center Rotterdam, The Netherlands.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Norio R. Finnish Disease Heritage I: characteristics, causes, background. Hum Genet 2003; 112:441-56. [PMID: 12627295 DOI: 10.1007/s00439-002-0875-3] [Citation(s) in RCA: 121] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2002] [Accepted: 10/30/2002] [Indexed: 01/01/2023]
Abstract
This review of the Finnish Disease Heritage (FDH), a group of rare hereditary diseases that are overrepresented in Finland, includes the following topics: FDH characteristics, causes and background, primary theory, revis(it)ed theory, consanguineous marriages in Finland, internal migration of the 1500s, family series for further FDH studies, geography and population structure as a basis for FDH, geography of individual diseases, the structure of FDH families, family structure in individual diseases, Finnish gene mutations, linkage disequilibrium and haplotypes, age of gene mutations, frequencies of disease genes and carriers, and a short description of the possible future of FDH.
Collapse
Affiliation(s)
- Reijo Norio
- Department of Medical Genetics, The Family Federation of Finland, Helsinki, Finland.
| |
Collapse
|
31
|
Katoh T, Mano S, Ikuta T, Munkhbat B, Tounai K, Ando H, Munkhtuvshin N, Imanishi T, Inoko H, Tamiya G. Genetic isolates in East Asia: a study of linkage disequilibrium in the X chromosome. Am J Hum Genet 2002; 71:395-400. [PMID: 12082643 PMCID: PMC379171 DOI: 10.1086/341608] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2002] [Accepted: 05/02/2002] [Indexed: 11/03/2022] Open
Abstract
The background linkage disequilibrium (LD) in genetic isolates is of great interest in human genetics. Although many empirical studies have evaluated the background LD in European isolates, such as the Finnish and Sardinians, few data from other regions, such as Asia, have been reported. To evaluate the extent of background LD in East Asian genetic isolates, we analyzed the X chromosome in the Japanese population and in four Mongolian populations (Khalkh, Khoton, Uriankhai, and Zakhchin), the demographic histories of which are quite different from one another. Fisher's exact test revealed that the Japanese and Khalkh, which are the expanded populations, had the same or a relatively higher level of LD than did the Finnish, European American, and Sardinian populations. In contrast, the Khoton, Uriankhai, and Zakhchin populations, which have kept their population size constant, had a higher background LD. These results were consistent with previous genetic anthropological studies in European isolates and indicate that the Japanese and Khalkh populations could be utilized in the fine mapping of both complex and monogenic diseases, whereas the Khoton, Uriankhai, and Zakhchin populations could play an important role in the initial mapping of complex disease genes.
Collapse
Affiliation(s)
- T Katoh
- Department of Genetic Information, Division of Molecular Life Science, School of Medicine, Tokai University, Bohseidai, Isehara, Kanagawa 259-1193, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Tuulio-Henriksson A, Haukka J, Partonen T, Varilo T, Paunio T, Ekelund J, Cannon TD, Meyer JM, Lönnqvist J. Heritability and number of quantitative trait loci of neurocognitive functions in families with schizophrenia. AMERICAN JOURNAL OF MEDICAL GENETICS 2002; 114:483-90. [PMID: 12116181 DOI: 10.1002/ajmg.10480] [Citation(s) in RCA: 69] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Despite evidence for several chromosomal loci linked to schizophrenia, no susceptibility genes have been identified for the disorder. Using quantitative measures of phenotypic affection in place of clinical diagnostic categories or dichotomous classification of the affection status may be more effective in searching for susceptibility genes. Neurocognitive traits have been suggested as putative quantitative endophenotypes of the disorder, but their heritability estimates are not well known. We investigated the heritability of working memory, verbal declarative memory and its different components, and both verbal and visual ability functions in schizophrenia families with a well-ascertained pedigree structure. We also estimated the number of quantitative trait loci (QTLs) contributing to these neurocognitive functions. Additive genetic heritability of the neurocognitive functions was estimated in a sample of schizophrenia patients and their first-degree relatives (N = 264) from an isolated geographical subregion in Finland. The number of QTLs was analyzed using Markov chain Monte Carlo segregation analysis. Significant heritabilities were found in working memory and ability functions. Furthermore, the working memory functions revealed the most restricted number of QTLs. The mean numbers of loci for verbal and visual working memory were 1.2 and 1.0, respectively, with corresponding posterior probabilities of 73% and 70% for at least one locus. In declarative memory variables, the number of loci was more dispersed. Our results suggest that neurocognitive measures, particularly working memory, may provide valid quantitative phenotypic traits for linkage analyses searching predisposing genes for schizophrenia.
Collapse
Affiliation(s)
- Annamari Tuulio-Henriksson
- Department of Mental Health and Alcohol Research, National Public Health Institute of Finland, Helsinki.
| | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Jorgensen TH, Degn B, Wang AG, Vang M, Gurling H, Kalsi G, McQuillin A, Kruse TA, Mors O, Ewald H. Linkage disequilibrium and demographic history of the isolated population of the Faroe Islands. Eur J Hum Genet 2002; 10:381-7. [PMID: 12080390 DOI: 10.1038/sj.ejhg.5200816] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2001] [Revised: 03/01/2002] [Accepted: 04/09/2002] [Indexed: 11/09/2022] Open
Abstract
The isolated population of the Faroe Islands has a history of recent expansion after being limited to a small size for centuries. Such an isolated population may be ideal for linkage disequilibrium mapping of disease genes if linkage disequilibrium (LD) extends over large regions. Analyses of 18 markers on 12q24.3, spanning a region of 4.3 Mb (16 cM), revealed extensive LD in the Faroese population. Maximum LD was found between marker pairs separated by more than 3.8 Mb. The same region had a maximum LD of only 1.2 and 1.4 Mb respectively in two outbred Danish and British populations analysed here for comparison. The analyses of gene diversity excess at 15 unlinked microsatellite markers did not reveal any sign of a severe bottleneck to have occurred within approximately 1200 years' history of the Faroese population. The extensive LD in this population may, therefore, have arisen primarily by random genetic drift. The implications for future gene mapping studies are discussed.
Collapse
Affiliation(s)
- Tove H Jorgensen
- Institute for Basic Psychiatric Research, Department of Psychiatric Demography, Psychiatric Hospital in Aarhus, Aarhus University Hospital, Denmark.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Bourgain C, Genin E, Clerget-Darpoux F. Comparison of family based haplotype methods using intragenic SNPs in candidate genes. Eur J Hum Genet 2002; 10:313-9. [PMID: 12082506 DOI: 10.1038/sj.ejhg.5200808] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2002] [Revised: 03/18/2002] [Accepted: 03/20/2002] [Indexed: 11/08/2022] Open
Abstract
The choice of an optimal marker strategy while analysing intragenic SNPs is presently of crucial importance, given the increasing amount of available data. Classical case/control association studies or family based association tests such as the TDT are very popular. However, as these methods are not able to analyse multiple markers simultaneously, different extensions have been proposed in order to use multiple markers. In the present study, the efficiency of five family based haplotypic methods to detect the role of candidate genes is evaluated and compared between them and with the classical single point TDT. Simulations of intragenic SNP maps are performed in recently founded populations. One or several SNPs are assumed to be the functional polymorphisms following different genetic models. Different modes of SNP combinations underlying the genetic susceptibility (epistasis or heterogeneity) are considered. Whereas haplotypic methods perform better in situations of heterogeneity, the TDT remains the most powerful approach in epistasis models as long as the marginal effect of one the SNPs involved in the susceptibility remains important. Haplotypic methods perform better than the TDT when the marginal effect of each SNP is small. Given the similar characteristics of intragenic LD in both old large populations and recently founded populations, in particular the weak correlation between LD and distance, our results are not likely to be specific to founder populations and can be generalized.
Collapse
Affiliation(s)
- Catherine Bourgain
- Unité de Recherche d'Epidémiologie Génétique, INSERM U535, Kremlin-Bicêtre, France.
| | | | | |
Collapse
|
35
|
Lehmann DJ, Williams J, McBroom J, Smith AD. Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. Neuroscience 2002; 108:541-54. [PMID: 11738493 DOI: 10.1016/s0306-4522(01)00464-x] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
In late-onset Alzheimer's disease, there is a puzzling inconsistency between the findings of case-control studies of most proposed risk genes, except apolipoprotein E epsilon4. This inconsistency may stem from the failure to define the genetic and non-genetic interactions that affect the disease association of each particular susceptibility gene. Such interactions will limit the influence of the gene to a 'relevant subset' of vulnerable people. The relevant subsets for many risk genes will be narrow, compared to that of apolipoprotein E epsilon4. Studies may therefore miss the association or even suggest that a risk gene is protective. In these circumstances, the precise composition of a cohort is critical and defining the relevant subset is crucial. We illustrate how such definition may be achieved through meta-analysis. We take as an example the butyrylcholinesterase K variant, whose association with Alzheimer's disease may now be provisionally defined. This analysis leads to the identification of a potentially high-risk group: over 75 year old male carriers of both apolipoprotein E epsilon4 and butyrylcholinesterase K variant.
Collapse
Affiliation(s)
- D J Lehmann
- Oxford Project To Investigate Memory and Ageing (OPTIMA), Radcliffe Infirmary, Oxford, UK.
| | | | | | | |
Collapse
|
36
|
Kaessmann H, Zöllner S, Gustafsson AC, Wiebe V, Laan M, Lundeberg J, Uhlén M, Pääbo S. Extensive linkage disequilibrium in small human populations in Eurasia. Am J Hum Genet 2002; 70:673-85. [PMID: 11813132 PMCID: PMC384945 DOI: 10.1086/339258] [Citation(s) in RCA: 60] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2001] [Accepted: 12/10/2001] [Indexed: 11/04/2022] Open
Abstract
The extent of linkage disequilibrium (LD) was studied in two small food-gathering populations-Evenki and Saami-and two larger food-producing populations-Finns and Swedes-in northern Eurasia. In total, 50 single-nucleotide polymorphisms (SNPs) from five genes were genotyped using real-time pyrophosphate DNA sequencing, whereas 14 microsatellites were genotyped in two X-chromosomal regions. In addition, hypervariable region I of the mtDNA was sequenced to shed light on the demographic history of the populations. The SNP data, as well as the microsatellite data, reveal extensive levels of LD in Evenki and Saami when compared to Finns and Swedes. mtDNA-sequence variation is compatible with constant population size over time in Evenki and Saami but indicates population expansion in Finns and Swedes. Furthermore, the similarity between Finns and Swedes in SNP allele- and haplotype-frequency distributions indicate that these two populations may share a recent common origin. These findings suggest that populations such as the Evenki and the Saami, rather than the Finns, may be particularly suited for the initial coarse mapping of common complex diseases.
Collapse
Affiliation(s)
- Henrik Kaessmann
- Max Planck Institute for Evolutionary Anthropology, Leipzig; Royal Institute of Technology, Stockholms Center for Physics, Astronomy and Biotechnology, Department of Biotechnology, Stockholm; and University of Tartu Institute of Molecular and Cell Biology, Estonian Biocentre, Tartu, Estonia
| | - Sebastian Zöllner
- Max Planck Institute for Evolutionary Anthropology, Leipzig; Royal Institute of Technology, Stockholms Center for Physics, Astronomy and Biotechnology, Department of Biotechnology, Stockholm; and University of Tartu Institute of Molecular and Cell Biology, Estonian Biocentre, Tartu, Estonia
| | - Anna C. Gustafsson
- Max Planck Institute for Evolutionary Anthropology, Leipzig; Royal Institute of Technology, Stockholms Center for Physics, Astronomy and Biotechnology, Department of Biotechnology, Stockholm; and University of Tartu Institute of Molecular and Cell Biology, Estonian Biocentre, Tartu, Estonia
| | - Victor Wiebe
- Max Planck Institute for Evolutionary Anthropology, Leipzig; Royal Institute of Technology, Stockholms Center for Physics, Astronomy and Biotechnology, Department of Biotechnology, Stockholm; and University of Tartu Institute of Molecular and Cell Biology, Estonian Biocentre, Tartu, Estonia
| | - Maris Laan
- Max Planck Institute for Evolutionary Anthropology, Leipzig; Royal Institute of Technology, Stockholms Center for Physics, Astronomy and Biotechnology, Department of Biotechnology, Stockholm; and University of Tartu Institute of Molecular and Cell Biology, Estonian Biocentre, Tartu, Estonia
| | - Joakim Lundeberg
- Max Planck Institute for Evolutionary Anthropology, Leipzig; Royal Institute of Technology, Stockholms Center for Physics, Astronomy and Biotechnology, Department of Biotechnology, Stockholm; and University of Tartu Institute of Molecular and Cell Biology, Estonian Biocentre, Tartu, Estonia
| | - Mathias Uhlén
- Max Planck Institute for Evolutionary Anthropology, Leipzig; Royal Institute of Technology, Stockholms Center for Physics, Astronomy and Biotechnology, Department of Biotechnology, Stockholm; and University of Tartu Institute of Molecular and Cell Biology, Estonian Biocentre, Tartu, Estonia
| | - Svante Pääbo
- Max Planck Institute for Evolutionary Anthropology, Leipzig; Royal Institute of Technology, Stockholms Center for Physics, Astronomy and Biotechnology, Department of Biotechnology, Stockholm; and University of Tartu Institute of Molecular and Cell Biology, Estonian Biocentre, Tartu, Estonia
| |
Collapse
|
37
|
Abstract
A population of about 5 million at the northern corner of Europe is unlikely to arouse the attention of the human genetics community, unless it offers something useful for others to learn. A combination of coincidences has finally made this population one that, out of proportion for its size, has by example shaped research in human disease genetics. This chapter summarizes advances made in medical genetics that are based on research facilitated by Finland's population structure. The annotation of the human genome for its polymorphism and involvement in disease is not over; it is, therefore, of interest to assess whether genetic studies in populations such as the Finnish might help in the remaining tasks.
Collapse
Affiliation(s)
- J Kere
- Finnish Genome Center, University of Helsinki, Helsinki 00014, Finland.
| |
Collapse
|
38
|
Pajukanta P, Cargill M, Viitanen L, Nuotio I, Kareinen A, Perola M, Terwilliger JD, Kempas E, Daly M, Lilja H, Rioux JD, Brettin T, Viikari JSA, Rönnemaa T, Laakso M, Lander ES, Peltonen L. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet 2000; 67:1481-93. [PMID: 11078477 PMCID: PMC1287925 DOI: 10.1086/316902] [Citation(s) in RCA: 126] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2000] [Accepted: 10/09/2000] [Indexed: 12/15/2022] Open
Abstract
Coronary heart disease (CHD) is a complex disorder constituting a major health problem in Western societies. To assess the genetic background of CHD, we performed a genomewide linkage scan in two study samples from the genetically isolated population of Finland. An initial study sample consisted of family material from the northeastern part of Finland, settled by a small number of founders approximately 300 years ago. A second study sample originated from the southwestern region of Finland, settled approximately 2,000 years ago. Families were ascertained through probands exhibiting premature CHD, defined as >50% stenosis of at least two coronary arteries at a young age, as verified by coronary angiography. Both study samples and the pooled data set provided evidence for linkage in two chromosomal regions. A region on chromosome 2q21.1-22 yielded two-point LOD scores of 3.2, 1.9, and 3.7, in the affected sib-pair (ASP) analyses of the northeastern, southwestern, and pooled study samples. The corresponding multipoint maximum-likelihood scores (MLSs) for these three study samples were 2.4, 1.3, and 3.0. In addition, a region on chromosome Xq23-26 resulted in two-point LOD scores of 1.9, 3.5, and 2.9 and in multipoint MLSs of 3.4, 3.1, and 2.5, respectively. In conclusion, this study identifies two loci likely to contribute to premature CHD: one on chromosome 2q21.1-22 and another on chromosome Xq23-26.
Collapse
Affiliation(s)
- Päivi Pajukanta
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Michele Cargill
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Laura Viitanen
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Ilpo Nuotio
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Anu Kareinen
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Markus Perola
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Joseph D. Terwilliger
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Elli Kempas
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Mark Daly
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Heidi Lilja
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - John D. Rioux
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Thomas Brettin
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Jorma S. A. Viikari
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Tapani Rönnemaa
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Markku Laakso
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Eric S. Lander
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| | - Leena Peltonen
- Department of Human Molecular Genetics, National Public Health Institute, Helsinki; Department of Human Genetics, Gonda Neuroscience and Genetics Research Center, University of California Los Angeles, Los Angeles; Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA; Department of Medicine, University of Kuopio, Kuopio, Finland; Department of Medicine, University of Turku, Turku, Finland; and Department of Psychiatry and Columbia Genome Center, Columbia University, New York
| |
Collapse
|
39
|
Abstract
Geneticists have repeatedly turned to population isolates for mapping and cloning Mendelian disease genes. Population isolates possess many advantages in this regard. Foremost among these is the tendency for affected individuals to share ancestral haplotypes derived from a handful of founders. These haplotype signatures have guided scientists in the fine mapping of scores of rare disease genes. The past successes with Mendelian disorders using population isolates have prompted unprecedented interest among medical researchers in both the public and private sectors. Despite the obvious genetic and environmental complications, geneticists have targeted several population isolates for mapping genes for complex diseases.
Collapse
Affiliation(s)
- L Peltonen
- Department of Medical Genetics, University of Helsinki and National Public Health Institute, Finland.
| | | | | |
Collapse
|
40
|
Affiliation(s)
- K M Weiss
- Departments of Anthropology and Biology, Penn State University, University Park, Pennsylvania, USA.
| | | |
Collapse
|